Alzheimer's Disease Trial, Recruiting NCT03657732 Sponsor: Capital Medical University Condition: Alzheimer's Disease
Back to Alzheimers Disease

Alzheimer's Disease Trial, Recruiting

NCT03657732
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

If you come from a family with Alzheimer's disease (Familial AD group):

  • You are willing and able to give written agreement to take part (or a legal guardian can do this on your behalf)
  • At least two close relatives (like parents or siblings) in your family have been diagnosed with Alzheimer's disease, and at least 3 people across 2 generations in your family have the condition
  • At least one person in your family has normal memory and thinking ability, and is older than the average age when Alzheimer's started in your family
  • Your family carries a known gene change linked to inherited Alzheimer's disease (in the APP, PSEN1, or PSEN2 genes)
  • You are over 18 years old and belong to this family
  • Your memory and thinking are either normal or affected by dementia, but you are not completely bedridden
  • You can provide two reliable people who know you well and can share information about your health and daily life
  • Your memory or thinking problems, if any, have been formally diagnosed using recognised medical guidelines (confirm with trial site)

If you are a healthy volunteer (Normal Control group):

  • You are 18 years old or older
  • You score within the normal range on standard memory and thinking tests, based on your level of education (confirm with trial site for exact score requirements)

Who may not be able to join:

Familial AD group:

  • Your memory or thinking problems are caused by something other than Alzheimer's, such as depression, thyroid problems, a brain injury, brain tumour, or another type of dementia (e.g. vascular dementia or Lewy body dementia)
  • Your brain scan (MRI) or blood test results do not clearly support an Alzheimer's diagnosis
  • You have a serious ongoing illness affecting your heart, lungs, kidneys, digestive system, blood, or you have cancer (for example, unstable chest pain, uncontrolled asthma, or active stomach bleeding)
  • You have a severe mental health condition or are so severely affected by dementia that you cannot take part in assessments
  • You have a history of alcohol or drug misuse
  • You are pregnant or breastfeeding
  • You cannot provide two reliable people who know you well to share information about you
  • For spinal fluid collection (lumbar puncture): you have a blood clotting problem, a very low platelet count, had spinal surgery in the last 6 months that affects the spine's structure, or have a history of repeated fluid leaks after previous spinal procedures
  • For brain scans (MRI): you have metal implants such as a pacemaker, artificial heart valve, metal joint, or metal in the eye, or have an aneurysm clip in the brain

Normal Control group:

  • Your memory and thinking test scores fall outside the normal range
  • You have a history of stroke, brain injury, or related findings on a brain scan
  • You have a neurological condition that can affect brain function, such as Parkinson's disease, epilepsy, depression, or a brain tumour
  • You have another health condition known to affect memory and thinking, such as liver, kidney, or thyroid problems, severe anaemia, vitamin deficiencies, syphilis, HIV, or a history of alcohol or drug misuse
  • You have an intellectual or developmental disability
  • You have a condition that prevents you from completing memory and thinking assessments (confirm with trial site)
  • You have a reason you cannot safely have an MRI scan
  • You are unwilling to have a blood test
  • You are unwilling to sign the consent form at the start of the study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 15 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Jianping Jia, Doctor, Xuanwu Hospital of Capital Medical University

Phone: +8610-83199449

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Capital Medical University
Registry
ClinicalTrials.gov
Start date
10 January 2005
Est. completion
1 January 2038

Where this trial is recruiting

🇨🇳 China

Primary endpoints

The prevalence of gene mutations in familial Alzheimer's disease in China.; The development patterns of genetic, biofluid, imaging, and neuropsychological markers of FAD.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov